IAD Index of Academic Documents
  • Home Page
  • About
    • About Izmir Academy Association
    • About IAD Index
    • IAD Team
    • IAD Logos and Links
    • Policies
    • Contact
  • Submit A Journal
  • Submit A Conference
  • Submit Paper/Book
    • Submit a Preprint
    • Submit a Book
  • Contact
  • Genel Tıp Dergisi
  • Volume:34 Issue:6
  • Examination of Vitamin-D Levels in Patients with Schizophrenia and Schizoaffective Disorder: A Retro...

Examination of Vitamin-D Levels in Patients with Schizophrenia and Schizoaffective Disorder: A Retrospective Study

Authors : Selin Balki Tekin, Ayşe Nur İnci Kenar, Ayşenur Tecim Gökçedağ
Pages : 827-831
Doi:10.54005/geneltip.1524630
View : 78 | Download : 94
Publication Date : 2024-12-31
Article Type : Research Paper
Abstract :ABSTRACT Background/Aims: The relationship between vitamin D and schizophrenia has been the focus of studies in the last 20 years. Studies have shown that approximately 65% of schizophrenia patients have vitamin D deficiency. This study aimed to retrospectively investigate the vitamin D levels of schizophrenia and schizoaffective disorder (SAD) patients receiving inpatient treatment at a tertiary care hospital. Material and Methods: Patients diagnosed with Schizophrenia and SAD who received inpatient treatment at the psychosis service of a tertiary care hospital in the last two years (2021-2023) were included in this study. The data of 230 patients were examined retrospectively from hospital and file records. Results: Among the patients in the study, 47.8% were female with a mean age of 42.3±15.8 years, and 52.2% were male with a mean age of 37.2±14.1 years. Among women, 24.5% had SAD and 75.5% had schizophrenia, among men, 30.8% had SAD and 69.2% had schizophrenia. Vitamin D deficiency was found in 73% of the group, vitamin D insufficiency was found in 17.4%, and normal vitamin D levels were found in 9.6%. No statistically significant relationship was found when vitamin D levels were compared between male and female patient groups (p = 0.068). When vitamin D levels were compared between patient groups diagnosed with schizophrenia and SAD, no statistically significant relationship was found. (p>0.05) Conclusion: Despite advances in the treatment of schizophrenia, these advances are insufficient to reduce the morbidity and mortality of the disease, so prophylactic measures should be explored. Adequate D vitamin supplementation during critical stages of life, including pregnancy, may be a meaningful, simple, safe, and cost-effective intervention.
Keywords : schizoaffective disorder, schizophrenia, vitamin D deficiency, vitamin D insufficiency, retrospective study

ORIGINAL ARTICLE URL

* There may have been changes in the journal, article,conference, book, preprint etc. informations. Therefore, it would be appropriate to follow the information on the official page of the source. The information here is shared for informational purposes. IAD is not responsible for incorrect or missing information.


Index of Academic Documents
İzmir Academy Association
CopyRight © 2023-2026